Center For AIDS Research

September 10-17, 2012

If you have problems viewing this email click here to open The Network News in your browser.
The Network News
September 10-17, 2012
Picture of the Week...



Divider RuleKudos...


. . . to Ted Johnson on being recently named Director of the newly merged Division of General Medicine and Geriatrics.
Read All About It

. . . to Keith Klugman for developing the first-ever index for drug resistance.
Get the Scoop

. . to Kimbi Hagen who storied career at Emory was featured in the recent Health Science Update.
Read the article.

Divider RuleIn other news...

Happy Birthday

... to Adam Carpenter (August 24), Carlos del Rio (August 28), Lilin Lai (September 8), Safiya George Dalmida (September 13), Jim Curran and Frank Wong (September 16).

Birthdays are good for you. Statistics show that the people who have the most birthdays live the longest. (Larry Lorenzoni)

CyTOF machine

...We recently got news of an award (>$750,000) from the NIH to purchase a DVS Sciences' CyTOF™ (mass Cytometry Time of Flight) machine. The award was made through through the CHAVI-ID grant (Rafi Ahmed, PI). Having a CyTOF is a potential game-changer for Emory's immunology and HIV research. The CyTOF will be shared between the CFAR Immunology Core and the EVC Flow Core, both directed by John Altman.

Divider Rule Bulletin Board...

bulletin board

Study Subjects Sought:
Mary Jo Lechowicz is looking for study subjects for the AIDS Malignancy Clinical Trials Consortium Protocol #053 ("Safety and efficacy pilot trial of the anti-viral and anti-tumor activity of Velcade combine with (R)ICE in subjects with relapsed/refractory AIDS-associated lymphoma"). Please alert Mary Jo or study coordinator Amanda Colbert if you can assist in locating a study subject.
Read the inclusion/exclusion criteria

Position Sought:
by Michelle Sturgis, BS, MPH. Michelle's 1 year contract at the CDC is ending and she is on the hunt for another position as an epidemiologist or laboratorian. She has diverse public health experience at the state and Federal level and extensive research skills in conducting projects both domestically and with an international focus. She is proficient in managing large, complex data sets and has trained graduate and undergraduate students in molecular and cellular techniques.
Download her CV.

Position Available:
Vitaly Ganusov has written to advertise an Assistant Professor-level tenure-track postion in Immunology with the Department of Microbiology at the University of Tennessee, Knoxville. Candidates with active research programs focusing on innate immune responses to infection and/or host-pathogen interactions using cellular and molecular immunologic methodologies are encouraged to apply. Review of applicants will begin November 1, 2012 and continue until the position is filled.  Position to begin August 1, 2013.
Read the announcement



Divider Rule

New Funding Opps

Oct 19 (LOI)
November 19 (Application) Sponsor: NIDA
The Interplay of Substance Abuse and HIV-1 Infection on Glial Cell Function

Oct 9 (Application)
Sponsor: NIH Common Fund
2013 NIH Director's Pioneer Award Program

Oct 17 (Application)
Sponsor: NIH Common Fund
2013 NIH Director's New Innovator Award Program

Nov 1 (App)
Sponsor: CFAR
Request for Applications in HIV/AIDS

Nov 1 (App)
Sponsor: CFAR
Request for Applications in Pediatric/Adolescent HIV/AIDS



Nov 1 – Dec 31 (Apps)
Sponsor: CDC
Orise Fellowship
Post-Doctoral Research Fellowships for HIV Prevention in Communities of Color


Divider Rule pubs

Recent Pubs
that acknowledge the CFAR grant (P30 AI050409)

Seigler AJ, Mbwambo JK, McCarty FA, DiClemente RJ.
Condoms "contain worms" and "cause HIV" in Tanzania: Negative condom belies scale development and implications for HIV prevention
Soc sci med. 2012 Jul 27 [Epub ahead of print].

Huang ZJ, He N, Nehl EJ, Zheng T, Smith BD, Zhang J, McNabb S, Wong FY.
Social network and other correlates of HIV testing: Findings from male sex workers and other MSM in Shanghai, China
AIDS Behav. 2012 May; 16(4):858-71.

Vanderford TH, Slichter C, Rogers KA, Lawson BO, Obaede R, Else J, Villinger F, Bosinger SE, Silvestri G.
Treatmentof SIV-infected sooty mangabeys with type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation.
Blood. 2012 Jun 14; 119(24):5750-7. Epub 2012 May 1.

Wagenaar BH, Christiansen-Lindquist L, Khosropour C, Salazar LF, Benbow N, Prachand N, Sineath RC, Stephenson R, Sullivan PS.
Willingness of US Men Who Have Sex with Men (MSM) to Participate in Couples HIV Voluntary Counseling and Testing (CVCT).
PLoS One. 2012; 7(8); e42953.Epub 2012 Aug 14.

Kilembe W, Keeling M, Karita E, Lakhi S, Chetty P, Price MA, Makkan H, Latka M, Likoti M, Ilukui K, Hurlston M, Allen S, Stevens G, Hunter E.
Failure of a novel, rapid antigen and antibody combination test to detect antigen-positive HIV infection in African adults with early HIV infection.
PLoS One. 2012;7(6):e37154. Epub 2012 Jun 8.

calendar Upcoming Events
Sept 12-14
Bridging the Sciences
Location: Emory Conference Center
See "Spotlight" section below

Sept 13
ID Seminar
Disabling drug-resistant microbial pathogens: From cell biology to a translational strategy
  Daniel Kalman, PhD

Location: Rita Anne Rollins Room, 8th Floor, RSPH/GCR


calendar Save the Date: New
2013 Keystone Symposia
September deadlines

October 10 (Abstract Deadline)
X1: B-cell Development and Function (X1)
X2: AIDS Vaccines
Date: Feb 10-15, 2013
Location: Keystone Resort, CO

November 2-4
2012 Clinical Vaccinology Course
Sponsors: Natl Foundation for Infectious Disease, Emory ID Division, Emory Vaccine Center
Location: Hyatt Regency, Miami

Nov 1 (Early Registration)
Dec 1 (Abstract Submission)
CN Workshop
HIV Cure and Eradication: A Feasible Option?
Date: January 24-25, 2013
Location: Palazzo delle Stelline, Milan, Italy


Divider Rule spotlight

Spotlight! | 'Bridging the Sciences' Conference: S2E-HCV Workshop: Seek, Test, Treat, Eradicate HCV

Bridging the Sciences

Dr. Raymond Schinazi, CFAR HIV Eradication Scientific Working Group Director, invites you to attend this premier HCV Workshop, which will assemble world experts from academia, industry, non-profit organizations and government institutions, to prepare, plan, synergize and ultimately implement this truly worthwhile large-scale humanitarian effort.

• A New Path to HCV Eradication
• Identifying Whom to Treat and How
• Gobal Status of HCV Prevalence and Treatment
• Difficult to Treat Populations: Optimizing Access and Outcome
• Strategies to Eradicate: Discussion and Debate Panel

The discussion panel will showcase experts from academia, industry, finance, non-profit organizations and government institutions, to debate and formulate recommendations as to the means to achieving an organized effort to eradicate HCV infection in all individuals within a defined US region, using novel advanced oral therapies.

Online registration is available on the official Workshop website:
You must insert this VIP code to receive the discount: S2EStu4bd8

Tarik Asselah; Hôpital Beaujon, France
Beatrice Anduze-Faris; Bristol-Myers Squibb, USA
Carol Brosgart; Division of Global Health, UCSF, USA*
Scott Brun; Abbott Laboratories, USA
Steve Coats; RFS Pharma, LLC, USA*
Andrea Cox; Johns Hopkins University School of Medicine, USA
Douglas Dieterich; Mount Sinai School of Medicine, USA
Matthew Evans; Mount Sinai School of Medicine, USA
Debra Fraser-Howze; OraSure Technologies, Inc., USA
Jeffrey Glenn; Departments of Medicine and Microbiology & Immunology, Stanford University School of Medicine, USA
David Goldstein; Duke University, USA
Liesl Hagan; Emory University School of Medicine/School of Public Health, USA
Tarek Hassanein; Southern California Liver Centers, USA
Daria Hazuda; Merck & Co, Inc., US
AIra Jacobson; Weill Cornell Medical College, USA*
Saul Karpen; Emory University, USA *
Tara Kieffer; Vertex Pharmaceuticals, Inc., USA
Ann Kwong; InnovaTID, USA
Sandra Lehrman; Merck & Co., Inc., USA
Karen Lindsay; Janssen R&D, LLC, USA
Alain Litwin; Albert Einstein College of Medicine and Montefiore Medical Center, USA
Henry Masur; NIH, USA*
Geoffrey Meacham; J.P. Morgan Biotech Research, USA
Julio Montaner; BC Centre for Excellence in HIV/AIDS, Canada*
Andrew Muir; Duke University Medical Center, USA
Robert Murphy; Northwestern University, USA
Ponni Perumalswami; Mount Sinai School of Medicine, USA
Michael Polis; NIAID, USA
Charles Rice; The Rockefeller University, USA
Lorren Sandt; Caring Ambassadors Program, Inc., USA
Eugene Schiff; University of Miami, USA
Raymond Schinazi; Emory University/VA Medical Center, USA
Gloria Searson; Coalition On Positive Health Empowerment, USA
Suganya Selvarajah; University of California, San Francisco, USA
Anne Spaulding; Emory University, USA
Barbara Stoll; Emory University School of Medicine, USA
Mark Sulkowski; Johns Hopkins University School of Medicine, USA
John Sullivan-Bolyai; Idenix Pharmaceuticals, USA
David Thomas; Johns Hopkins Medical Institution, USA
John Ward; Centers for Disease Control and Prevention, USA*
David Witzke; PioneerPath Capital, USA
Paul Root Wolpe; Emory Center for Ethics, USA
Teresa Wright; Genentech, Inc., USA*

*Plenary Speaker


Divider Rule
CFAR logo

The Network News is a weekly email, detailing HIV/AIDS related events, funding opportunities, and achievements of CFAR members. If you have items that you wish to have included, please send them to us at by Friday of each week. Please put "The Network News" in the subject line.

The Network News is distributed to CFAR members by email every Monday. Except when it isn't.

Divider Rule
Emory University Center for AIDS Research click here to open The Network News in a browser Bulletin Board Funding Opportunities This Week's Events New Events Recent Publications Spotlight